Abstract
Targeting BH3 Domains in iPSC-Derived Tuberous Sclerosis Kidney Organoids for the Development of Novel Therapies for Renal Angiomyolipoma
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have